{
 "PrintNo":"S1758","Session":2023,"Chamber":"SENATE","BillType":"Senate","Published":"2023-01-13T15:26:52.872253Z",
 "Status":"IN_SENATE_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2024-01-03","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2023-01-13","Chamber":"SENATE"},
  {"Text":"REFERRED TO HEALTH","Date":"2024-01-03","Chamber":"SENATE"}
 ],
 "Sponsors":[{"ID":1232,"Name":"James Skoufis","Short":"SKOUFIS"}],
 "Title":"Relates to adding W-18 to the schedule of controlled substances",
 "Summary":"Adds W-18(4-chloro-N-{1-{2-(4-nitrophenyl)ethyl} 2piperidinylidene}benzenesulfonamide) to the schedule of controlled substances.",
 "LawSection":"Public Health Law","LawCode":"Amd ยง3306, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to adding W-18 to the schedule of controlled substances",
 "PreviousVersions":["S5112-2017","S5221-2019","S1774-2021"]
}